APA-referens

Mao, F., Li, J., Luo, Q., Wang, R., Kong, Y., Carlock, C., . . . Liu, X. (2018). Plk1 inhibition enhances the efficacy of BET epigenetic reader blockade in castration-resistant prostate cancer. Mol Cancer Ther.

Chicago-stil citat

Mao, Fengyi, Jie Li, Qian Luo, Ruixin Wang, Yifan Kong, Colin Carlock, Zian Liu, Bennet D. Elzey, och Xiaoqi Liu. "Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-resistant Prostate Cancer." Mol Cancer Ther 2018.

MLA-referens

Mao, Fengyi, et al. "Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-resistant Prostate Cancer." Mol Cancer Ther 2018.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.